Total occlusion of the infarct-related coronary artery correlates with brachial artery flow-mediated dilation in patients with ST-elevation myocardial infarction

References

• Kovacs I, Yamamoto J. Spontaneous thrombolysis: A forgotten determinant of life or death. Clinical and Applied Thrombosis/Hemostasis 2006; 12: 358–63
   PubMed Web of Science ®Google Scholar
• Christian T, Milavetz J, Miller T, Clements I, Holmes D, Gibbons R. Prevalence of spontaneous reperfusion and associated myocardial salvage in patients with acute myocardial infarction. Am Heart J. 1998; 135: 421–7
   PubMed Web of Science ®Google Scholar
• Stone C, Cox D, Garcia E, Brodie B, Morice M-C, Griffin J, Mattos L, Lansky A, O'Neill W, Grines C. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001; 104: 636–41
   PubMed Web of Science ®Google Scholar
• Celermajer D, Sorensen E, Gooch M, Spiegelhalter D, Miller O, Sullivan I, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–5
   PubMed Web of Science ®Google Scholar
• Moens AL, Goovaerts I, Claeys MJ, Vrints CJ. Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool?. Chest 2005; 127: 2254–63
   PubMed Web of Science ®Google Scholar
• Corretti M, Anderson T, Benjamin E, Celermajer D, Charbonneau F, Creager M, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. Am J Cardiol. 2002; 39: 257–65
   Web of Science ®Google Scholar
• Herrington D, Fan L, Drum M, Riley WA, Pusser B, Crouse J, et al. Brachial flow-mediated vasodilatior responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J.Cardiovasc Risk 2001; 8: 319–28
   PubMedGoogle Scholar
• Rimar D, Crystal E, Battler A, Gottlieb S, Freimark D, Hod H, et al. Improved prognosis.of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction. Heart 2002; 88: 352–6
   PubMed Web of Science ®Google Scholar
• Vaughan D. PAI-1 and atherothrombosis. J Thromb Haemost. 2005; 3: 1879–83
   PubMed Web of Science ®Google Scholar
• Lüscher T, Barton M. Biology of the endothelium. Clin Cardiol. 1997; 20: 3–10
   PubMed Web of Science ®Google Scholar
• Deanfield J, Halcox P, Rabelink T. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115: 1285–95
   PubMed Web of Science ®Google Scholar
• Joannides R, Haefeli W, Linder L, Richard V, Bakkali E, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 9: 1314–9
   Web of Science ®Google Scholar
• Lüscher, TF. Endothelial dysfunction: the role and impact of the renin-angiotensin system. Heart 2000;84(Suppl. 1)i20–2, i50.
   Google Scholar
• Su Y, Liu XM, Sun YM, Wang YY, Luan Y, Wu Y. Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus. Am J Cardiol. 2008; 102: 497–8
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 1997; 96: 3287–93
   PubMed Web of Science ®Google Scholar
• Pasceri V, Willerson ST, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165
   PubMed Web of Science ®Google Scholar
• Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002; 106: 1439–41
   PubMed Web of Science ®Google Scholar
• Devaraj S, Yan Xu D, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: Implications for the metabolic syndrome and atherothrombosis. Circulation 2003; 107: 398–404
   PubMed Web of Science ®Google Scholar
• Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol. 2000; 35: 60–6
   PubMed Web of Science ®Google Scholar
• Bots, ML, Remme, WJ, Lüscher, TF, Fox, KM, Bertrand, M, Ferrari, R,, EUROPA-PERFECT Investigators, et al. ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trial. Cardiovasc Drugs Ther. 2007;21:269–79.
   PubMed Web of Science ®Google Scholar